Accuracy of the actibelt ® accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis

Gait and Posture

Volumn 35, Issue 2, 2012, Pages 192-196

  Motl, Robert W ^a   Weikert, Madeline ^a   Suh, Yoojin ^a   Sosnoff, Jacob J ^a   Pula, John ^b   Soaz, Cristina ^c   Schimpl, Michaela ^d   Lederer, Christian ^c   Daumer, Martin ^c,d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c Sylvia Lawry Center for Multiple Sclerosis Research   (Germany)

^d TRIUM ANALYSIS ONLINE GMBH   (Germany)

Author keywords

Free living; Multiple sclerosis; Validity; Walking

Indexed keywords

ACCELEROMETER; ACCURACY; ADULT; ARTICLE; BODY MASS; DISABILITY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FALLING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; WALKING SPEED;

ACCELERATION; ADULT; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; DISABILITY EVALUATION; ENERGY METABOLISM; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MUSCLE FATIGUE; PROGNOSIS; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TASK PERFORMANCE AND ANALYSIS; WALKING;

EID: 84856678167     PISSN: 09666362     EISSN: 18792219     Source Type: Journal    
DOI: 10.1016/j.gaitpost.2011.09.005     Document Type: Article

References (14)

1. Goldman M.D., Motl R.W., Rudick R.A. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord 2010, 3:229-239.
2. Pearson O.R., Busse M.E., van Deursen R.W., Wiles C.M. Quantification of walking mobility in neurological disorders. QJM 2004, 97:463-475.
3. Daumer M., Thaler K., Kruis E., Feneberg W., Staude G., Scholz M. Steps towards a miniaturized, robust and autonomous measurement device for the long-term monitoring of patient activity: ActiBelt. Biomed Technol 2007, 52:149-155.
4. Schlesinger S., Neuhaus A., Thiele A., Kippnich M., Rashid A., Griewing B., et al. Is it possible to measure mobility deficits of patients suffering from multiple sclerosis? Evaluation of mobility of patients with MS and motor dysfunctions by means of accelerometers. Klin Neurophysiol 2011, 42:17-21.
5. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
6. ® platform. PLos ONE 2011, 6:e23080.
7. Goldman M.D., Marrie R.A., Cohen J.A. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler 2008, 14:383-390.
8. Motl R.W., Dlugonski D., Suh Y., Weikert M., Agiovlasitis S., Fernhall B., et al. Multiple Sclerosis Walking Scale-12 and oxygen cost of walking. Gait Posture 2010, 31:506-510.
9. Confavreux C., Vukusic S., Adeline P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003, 126:770-782.
10. Gijbels D., Alders G., Van Hoof E., Charlier C., Relants M., Broekmans T., et al. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler 2010, 16:618-626.
11. Motl R.W., Dlugonski D., Suh Y., Weikert M., Fernhall B., Goldman M. Accelerometry and its association with objective markers of walking limitations in ambulatory adults with multiple sclerosis. Arch Phys Med Rehabil 2010, 91:1942-1947.
12. Sosnoff J.J., Goldman M.D., Motl R.W. Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data. Mult Scler 2010, 16:868-877.
13. Daumer M., Neuhaus A., Herbert J., Ebers G. Prognosis of the individual course of disease: the elements of time, heterogeneity, and precision. J Neurol Sci 2009, 287:S50-S55.
14. Ioannidis J.P.A. Why most published research findings are false. PLoS Med 2005, 2:e124.